ARCHIVES

Trial Links Potential Biomarkers To Drugs For Lung Cancer, To Help Target Therapies

This article is from The Cancer Letter archive.

Vol. 33 No. 4 | April 30, 2010

Download PDF Visit The Full Archive

Related Articles

In Brief NCI-FDA Relations Tops, DeVita Says; Upon Talks to Candidates For Prospective Division

November 24, 1978

VIB CIDAC contract Extended, No Gaps In CANCERGRAMS

June 15, 1984

FDA Encourages Randomized Trials For Medical Devices.

May 26, 2006

“Bring Contracts Under Control, Save $100,00 A Year,” Samuels Tells NCI

November 2, 1979

Ethics Commission To Take Up Again Compensation Issue

September 11, 1981

At Its Launch, STAR Trial Inherits Baggage Of Its Predecessor, P-1 Tamoxifin Study

June 4, 1999